The National Agency for Food and Drug Administration and Control has granted conditional approval for use of Russia’s Sputnik V COVID-19 vaccine in Nigeria.
Mojisola Adeyeye, Director-General of NAFDAC, announced this at a press conference in Abuja on Thursday.
The conditional approval was granted despite concerns raised by the World Health Organization and the European Union over the safety and efficacy of the vaccine.
Adeyeye, however, explained that despite the vaccine not getting approval from the World regulatory bodies, NAFDAC had done a thorough assessment of the vaccine.
She said: “Sputnik V is yet to receive the EUL approval and therefore was subjected to full six-months review by NAFDAC. The Agency was granted access to the dossiers and prior assessment reports of Moderna and AstraZeneca from the WHO website at different times over the past two months.
“The Agency did a thorough assessment of each vaccine and were found to have the quality, safety and efficacy attributes, with the benefits far outweighing the risks.”
Adeyeye also added that two other vaccines, Moderna and AstraZeneca of SK bioscience Co limited, Republic of Korea had been approved.
She said: “Moderna and AstraZeneca AZD1222 vaccines have received WHO EUL listing and were given expedited approvals.”